Microscopic Polyangiitis (MPA), Granulomatosis With Polyangiitis (GPA)
Conditions
Brief summary
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
Detailed description
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
Interventions
DRUGAvacopan
oral administration
Sponsors
Kissei Pharmaceutical Co., Ltd.
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events | 2 years |
Countries
Japan
Contacts
Primary ContactKazunori Abe, director
Outcome results
None listed